pyranoprofen has been researched along with Chondrosarcoma in 2 studies
pyranoprofen: RN given refers to unlabled parent cpd; structure given in first source
Chondrosarcoma: A slowly growing malignant neoplasm derived from cartilage cells, occurring most frequently in pelvic bones or near the ends of long bones, in middle-aged and old people. Most chondrosarcomas arise de novo, but some may develop in a preexisting benign cartilaginous lesion or in patients with ENCHONDROMATOSIS. (Stedman, 25th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Surgical resection is the only treatment for chondrosarcomas, because of their resistance to chemotherapy and radiotherapy; therefore, additional strategies are crucial to treat chondrosarcomas." | 1.48 | Anti-tumor effects of a nonsteroidal anti-inflammatory drug zaltoprofen on chondrosarcoma via activating peroxisome proliferator-activated receptor gamma and suppressing matrix metalloproteinase-2 expression. ( Abe, K; Aiba, H; Aoki, Y; Harashima, A; Hayashi, K; Higuchi, T; Inatani, H; Kato, T; Kimura, H; Miwa, S; Munesue, S; Murakami, H; Shimozaki, S; Takeuchi, A; Taniguchi, Y; Tsuchiya, H; Yamamoto, N; Yamamoto, Y, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Higuchi, T | 2 |
| Takeuchi, A | 2 |
| Munesue, S | 2 |
| Yamamoto, N | 2 |
| Hayashi, K | 2 |
| Harashima, A | 2 |
| Yamamoto, Y | 2 |
| Tsuchiya, H | 2 |
| Kimura, H | 1 |
| Miwa, S | 1 |
| Inatani, H | 1 |
| Shimozaki, S | 1 |
| Kato, T | 1 |
| Aoki, Y | 1 |
| Abe, K | 1 |
| Taniguchi, Y | 1 |
| Aiba, H | 1 |
| Murakami, H | 1 |
2 other studies available for pyranoprofen and Chondrosarcoma
| Article | Year |
|---|---|
A nonsteroidal anti-inflammatory drug, zaltoprofen, inhibits the growth of extraskeletal chondrosarcoma cells by inducing PPARĪ³, p21, p27, and p53.
Topics: Animals; Anti-Inflammatory Agents; Cell Cycle Proteins; Chondrosarcoma; Cyclin-Dependent Kinase Inhi | 2023 |
Anti-tumor effects of a nonsteroidal anti-inflammatory drug zaltoprofen on chondrosarcoma via activating peroxisome proliferator-activated receptor gamma and suppressing matrix metalloproteinase-2 expression.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Benzopyrans; Bone Neoplasms; Cell Line, Tumor; Cell | 2018 |